Showing results (211-220 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 25, 2026
Noninvasive Identification of Isocitrate Dehydrogenase 1/2 Mutation in Brainstem GliomasMarina Kushnirsky, Andrew L Lin, Tejus Bale, et al.
JCO Precision Oncology|February 20, 2026
Foundation Model Based on Routine Magnetic Resonance Imaging for Brain Tumor Molecular Profiling and Progression PredictionJunxian Li, Renhe Liu, Yuchen Xing, et al.
JCO Precision Oncology|March 9, 2026
Pretreatment KRAS-Mutant Circulating Tumor DNA Predicts Incidence and Patterns of Recurrence in Patients Undergoing Radiofrequency Ablation for Colorectal Liver Metastases: A Prospective AnalysisKe Lin, Cailun Wang, Bin Qiao, et al.
JCO Precision Oncology|November 20, 2024
Development of a Composite Score Based on Carbohydrate Antigen 19-9 Dynamics to Predict Survival in Carbohydrate Antigen 19-9-Producing Patients With Pancreatic Ductal Adenocarcinoma After Neoadjuvant TreatmentIngmar F Rompen, Elisabetta Sereni, Joseph R Habib, et al.
JCO Precision Oncology|March 12, 2019
Genomic Characterization of Upper-Tract Urothelial Carcinoma in Patients With Lynch SyndromeTimothy F Donahue, Aditya Bagrodia, François Audenet, et al.
JCO Precision Oncology|September 14, 2019
Expanded analysis of secondary germline findings from matched tumor/normal sequencing identifies additional clinically significant mutationsE Ileana Dumbrava, L Brusco, M Daniels, et al.
JCO Precision Oncology|January 30, 2023
Benchmarking Outcomes for Molecularly Characterized Synchronous Oligometastatic Non-Small-Cell Lung Cancer Reveals EGFR Mutations to Be Associated With Longer Overall SurvivalBrian De, Ahsan S Farooqi, Kyle G Mitchell, et al.
JCO Precision Oncology|January 30, 2023
The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United StatesCatherine Gutierrez, Shuji Ogino, Jeffrey A Meyerhardt, et al.
JCO Precision Oncology|March 9, 2023
Tumor Volume Nadir in Patients With ALK-Rearranged Non-Small-Cell Lung Cancer Treated With AlectinibMizuki Nishino, Zihan Wei, Emanuele Mazzola, et al.
JCO Precision Oncology|February 14, 2023
Understanding the Risk of Drug Interactions Between Ritonavir-Containing COVID-19 Therapies and Small-Molecule Kinase Inhibitors in Patients With CancerAshley M Hopkins, Michael J Sorich, Andrew J McLachlan, et al.
Pageof 140